Plain language summary of TASUKI-52: A study looking at nivolumab plus platinum chemotherapy and bevacizumab as a combined treatment for people with advanced or recurrent nonsquamous non-small cell lung cancer (NSCLC)
TASUKI-52 简明语言摘要:一项研究,旨在探讨纳武利尤单抗联合铂类化疗和贝伐单抗作为治疗晚期或复发性非鳞状非小细胞肺癌 (NSCLC) 患者的联合疗法。
期刊:Future Oncology
影响因子:2.6
doi:10.1080/14796694.2026.2617855
Sugawara, Shunichi; Lee, Jong-Seok; Kang, Jin-Hyoung; Kim, Hye Ryun; Inui, Naoki; Hida, Toyoaki; Lee, Ki Hyeong; Yoshida, Tatsuya; Tanaka, Hiroshi; Yang, Cheng-Ta; Inoue, Takako; Nishio, Makoto; Goto, Yasushi; Tamura, Tomohide; Yamamoto, Nobuyuki; Yu, Chong-Jen; Akamatsu, Hiroaki; Takahashi, Shigeru; Nakagawa, Kazuhiko